Targeted Protein Degradation Market to Reach $9.85 Billion by 2035
The Next Frontier in Drug Discovery In the evolving landscape of biopharmaceutical innovation, targeted protein degradation (TPD) is emerging as one of the most revolutionary therapeutic approaches. Unlike traditional inhibitors that merely block protein activity, TPD technologies such as PROTACs (Proteolysis-Targeting Chimeras) and molecular glues completely eliminate disease-causing proteins....
0 Commentarios 0 Acciones 389 Views 0 Vista previa
Patrocinados